Table 1 Univariate and multivariate analysis for overall survival
Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
Factor | Category | N (%) | HR (95% CI) | p | HR (95% Cl) | p |
Age | - | - | 1.02 (0.99–1.05) | 0.176 | ||
Sex | female | 45 (29.0) | - | |||
Male | 110 (71.0) | 1.54 (0.92–2.56) | 0.1 | |||
Anatomical location | Distal | 48 (31.0) | - | - | ||
Intrahepatic | 25 (16.1) | 2.20 (1.12–4.34) | 0.022 | 2.05 (1.04–4.07) | 0.039 | |
Perihilar | 82 (52.9) | 1.76 (1.04–2.99) | 0.036 | 1.46 (0.85–2.50) | 0.166 | |
Stage | I + IA/B + II + IIA/B | 113 (72.9) | - | - | ||
IIIA + IIIB + IIIC + IV + IVB | 42 (27.1) | 2.18 (1.39–3.42) | 0.001 | 1.84 (1.16–2.92) | 0.01 | |
Differentiation | Low + Medium low | 98 (63.2) | - | |||
Medium + High | 57 (36.8) | 0.98 (0.63–1.53) | 0.921 | |||
Molecular subtype | Metabolic & Proliferative-C2 | 99 (63.9) | - | - | ||
Mesenchymal & Immunosupressive-C1 | 56 (36.1) | 2.20 (1.43–3.38) | <0.001 | 2.02 (1.30–3.12) | 0.002 | |
